Pharma Panels

Three pharma-focused panels will be held during the 2025 American Peptide Symposium to engage thought leaders across industry.

The panels will take place from 8:00 PM – 10:00 PM on Monday, Tuesday, and Wednesday night. The cost is $400, to gain access to all three panels, in addition to conference registration. The total number of participants will be limited to 100 for each panel to encourage discussion across the group. The panels will cover the following topics.

Designing and Developing Orally Available Peptides

Monday 08:00 pm – 10:00 pm

Moderated by Kaustav Biswas,
Sr. Principal Scientist/Sr. Director, Merck

Panelists:
Ashok Bhandari, Executive Vice President, Chief Drug Discovery and Preclinical Development Officer, Protagonist Therapeutics
Gaurav Bhardwaj, Assistant Professor, University of Washington, Co-Founder Vilya
Callie Bryan, Scientific Director and Peptide Lead, Global Discovery Chemistry, Johnson and Johnson Innovative Medicines
Ryuji Hayashi, Group Head, Discovery Chemistry, Chugai Pharmaceutical Co., Ltd.
Josh Schwochert, Co-founder and CSO, Unnatural Products

Beyond Potency: PK, Formulation, IP, and More

Tuesday 08:00 pm – 10:00 pm

Moderated by Nicolas Boyer
Principal Scientist, Merck

Panelists:
Elisabetta Bianchi, Senior Director, Peptide Chemistry, IRBM
John DiMao, Patent Attorney, Senior Associate, Hodgson Russ LLP
Ruchia Duggal, Principal Scientist, Merck
Sivaneswary Genepathy, Associate Principal Scientist, AstraZeneca

Sustainability in Peptide Manufacturing

Wednesday 08:00 pm – 10:00 pm

Moderated by Michael Kopach
Associate VP, Eli Lilly

Panelists:
Fernando Albericio, Professor, University of KwaZulu-Natal
Matthew Bio, President and CEO, Snapdragon
Stefan Eissler, Vice President Peptide Manufacturing Upstream, Bachem
Dani Schultz, Director, Discovery Process Chemistry, Merck